{"id":109726,"date":"2021-12-08T09:29:27","date_gmt":"2021-12-08T14:29:27","guid":{"rendered":"https:\/\/paginiromanesti.ca\/?p=109726"},"modified":"2021-12-08T09:29:27","modified_gmt":"2021-12-08T14:29:27","slug":"pfizer-vaccinul-ramane-eficace-impotiva-variantei-omicron-dupa-3-doze","status":"publish","type":"post","link":"https:\/\/paginiromanesti.ca\/2021\/12\/08\/pfizer-vaccinul-ramane-eficace-impotiva-variantei-omicron-dupa-3-doze\/","title":{"rendered":"Pfizer: Vaccinul r\u0103m\u00e2ne eficace \u00eempotiva variantei Omicron dup\u0103 3 doze"},"content":{"rendered":"
Vaccinul anti-COVID-19 dezvoltat de Pfizer\/BioNTech este ”\u00een continuare eficace” contra variantei Omicron a coronavirusului, a transmis miercuri \u00eentr-un comunicat produc\u0103torul vaccinului, care dore\u015fte totu\u015fi s\u0103 realizeze p\u00e2n\u0103 la sf\u00e2r\u015fitul lunii martie un vaccin adaptat acestei noi variante, relateaz\u0103 AFP.<\/strong><\/p>\n Conform studiilor realizate \u00een laborator, ”vaccinul este \u00een continuare eficace \u00eempotriva COVID-19, de asemenea \u00eempotriva variantei Omicron, dac\u0103 este administrat \u00een trei doze”, dar aceasta variant\u0103 ”probabil nu este neutralizat\u0103 suficient dup\u0103 dou\u0103 doze”.<\/p>\n ”O a treia doz\u0103 creeaz\u0103 un nivel de anticorpi neutralizan\u0163i \u00eempotriva Omicron similar celui observat dup\u0103 dou\u0103 doze” \u00een cazul celorlalte variante ale coronavirusului SARS-CoV-2, au relevat testele efectuate \u00een laborator de companiile Pfizer \u015fi BioNTech.<\/p>\n ”De\u015fi dou\u0103 doze de vaccin pot oferi \u00een continuare o protec\u0163ie \u00eempotriva formei grave a bolii cauzate de varianta Omicron, este clar, conform acestor date preliminare, c\u0103 protec\u0163ia este ameliorat\u0103 cu o a treia doz\u0103 de vaccin”, a rezumat directorul general al Pfizer, Albert Bourla.<\/p>\n